Hana Pharm Co Ltd (293480) — Financial Flexibility Index
Hana Pharm Co Ltd (293480) has a Financial Flexibility Index of 0.21x as of June 2026. Free cash flow of ₩24.50 Billion (operating CF ₩6.91 Billion minus capex ₩17.59 Billion) represents 0% of total liabilities (₩114.94 Billion). Check cash flow reinvestment rate of Hana Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hana Pharm Co Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Hana Pharm Co Ltd across 10 annual periods. For the full cash flow conversion analysis, see 293480 cash flow conversion.
Annual Financial Flexibility Index for Hana Pharm Co Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Hana Pharm Co Ltd. Explore Hana Pharm Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | ₩40.36 Billion | ₩9.18 Billion | ₩104.73 Billion | ▼ -27.1% |
| 2024 | 0.53x | ₩38.51 Billion | ₩25.30 Billion | ₩72.83 Billion | ▲ +12.5% |
| 2023 | 0.47x | ₩33.09 Billion | ₩18.40 Billion | ₩70.40 Billion | ▼ -45.3% |
| 2022 | 0.86x | ₩66.65 Billion | ₩30.88 Billion | ₩77.57 Billion | ▼ -26.7% |
| 2021 | 1.17x | ₩60.47 Billion | ₩25.66 Billion | ₩51.60 Billion | ▲ +58.3% |
| 2020 | 0.74x | ₩32.72 Billion | ₩15.58 Billion | ₩44.20 Billion | ▼ -51.7% |
| 2019 | 1.53x | ₩65.45 Billion | ₩31.72 Billion | ₩42.70 Billion | ▲ +71.0% |
| 2018 | 0.90x | ₩33.16 Billion | ₩27.59 Billion | ₩36.99 Billion | ▲ +51.8% |
| 2017 | 0.59x | ₩35.57 Billion | ₩25.38 Billion | ₩60.25 Billion | ▲ +68.0% |
| 2016 | 0.35x | ₩20.77 Billion | ₩12.46 Billion | ₩59.11 Billion | — |